Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18085147 | 0.88 | TSHR (0.40) | MEN1HTTKMT2AALOX5TSHR | |
| SCHEMBL30294097 | 0.88 | TSHR (0.40) | MEN1HTTKMT2AALOX5TSHR | |
| SCHEMBL30468149 | 0.80 | SLC6A4 (0.38) | MEN1HTTKMT2ASLC6A4TDP1 | |
| SCHEMBL29098920 | 0.79 | SMN1; SMN2 (0.45) | SMN1; SMN2NPSR1MEN1HTTKMT2A | |
| SCHEMBL19274260 | 0.78 | THRA (0.51) | SLC6A4ALOX5PTGS2 | |
| SCHEMBL20303640 | 0.78 | USP28 (0.44) | SMN1; SMN2NPSR1MEN1HTTKMT2A | |
| SCHEMBL16596441 | 0.77 | S1PR1 (0.39) | SMN1; SMN2NPSR1MEN1HTTKMT2A | |
| SCHEMBL19506246 | 0.76 | THRA (0.49) | SLC6A4ALOX5PTGS2 | |
| SCHEMBL3853386 | 0.76 | SLC6A4 (0.40) | MEN1HTTKMT2ALMNASLC6A4 | |
| SCHEMBL29098918 | 0.76 | SMN1; SMN2 (0.45) | SMN1; SMN2NPSR1MEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9978954-B2 | Benzobis (thiadiazole) derivative, ink comprising same, and organic electronic device comprising same | UBE INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160276598-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK COMPRISING SAME, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | FUTURE INK CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276598-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK COMPRISING SAME, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | BRD3, TH, BRS3 | SMN1; SMN2 4013/4885NPSR1 4333/4885MEN1 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.